For years, biosecurity has existed on the margins of the investment landscape—acknowledged in theory, but rarely prioritised in practice. It has been treated as a government responsibility, a crisis response function, or at best, a specialised subset of healthcare. That framing is no longer sustainable. What is emerging now is a recognition that biological risk […]
